A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 9

Prediction of reaction to immunotherapy in patients with HCC. The violin plots show the distribution of the TIDE value in immunotherapy response between the TCGA (a) and ICGC cohort (c). The proportion of patients with response/no response to immunotherapy based on the two risk stratifications, in TCGA cohort (b) and in ICGC cohort (d).

(a)

(b)

(c)

(d)